Manuel Reina
Corporate Officer/Principal bei University of Barcelona
Aktive Positionen von Manuel Reina
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Barcelona | Corporate Officer/Principal | - | - |
Karriereverlauf von Manuel Reina
Ehemalige bekannte Positionen von Manuel Reina
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Advancell Advanced In Vitro Cell Technologies SL
 Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Manuel Reina
| Consejo Superior de Investigaciones Científicas | Doctorate Degree |
Statistik
International
| Spanien | 4 |
Operativ
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Advancell Advanced In Vitro Cell Technologies SL
Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Health Technology |
- Börse
- Insiders
- Manuel Reina
- Erfahrung
